ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Division Spotlight
Materials Science & Technology
The objectives of MSTD are: promote the advancement of materials science in Nuclear Science Technology; support the multidisciplines which constitute it; encourage research by providing a forum for the presentation, exchange, and documentation of relevant information; promote the interaction and communication among its members; and recognize and reward its members for significant contributions to the field of materials science in nuclear technology.
Meeting Spotlight
ANS Student Conference 2025
April 3–5, 2025
Albuquerque, NM|The University of New Mexico
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Feb 2025
Jul 2024
Latest Journal Issues
Nuclear Science and Engineering
March 2025
Nuclear Technology
Fusion Science and Technology
February 2025
Latest News
Colin Judge: Testing structural materials in Idaho’s newest hot cell facility
Idaho National Laboratory’s newest facility—the Sample Preparation Laboratory (SPL)—sits across the road from the Hot Fuel Examination Facility (HFEF), which started operating in 1975. SPL will host the first new hot cells at INL’s Materials and Fuels Complex (MFC) in 50 years, giving INL researchers and partners new flexibility to test the structural properties of irradiated materials fresh from the Advanced Test Reactor (ATR) or from a partner’s facility.
Materials meant to withstand extreme conditions in fission or fusion power plants must be tested under similar conditions and pushed past their breaking points so performance and limitations can be understood and improved. Once irradiated, materials samples can be cut down to size in SPL and packaged for testing in other facilities at INL or other national laboratories, commercial labs, or universities. But they can also be subjected to extreme thermal or corrosive conditions and mechanical testing right in SPL, explains Colin Judge, who, as INL’s division director for nuclear materials performance, oversees SPL and other facilities at the MFC.
SPL won’t go “hot” until January 2026, but Judge spoke with NN staff writer Susan Gallier about its capabilities as his team was moving instruments into the new facility.
Masahiro Saito
Fusion Science and Technology | Volume 41 | Number 3 | May 2002 | Pages 399-403
Biology | Proceedings of the Sixth International Conference on Tritium Science and Technology Tsukuba, Japan November 12-16, 2001 | doi.org/10.13182/FST02-A22619
Articles are hosted by Taylor and Francis Online.
In a series of experiments, the dosimetry of OBT in the mice supplied with THO or OBT directly or indirectly from their mothers was studied. In the offspring mice nursed by mother mice supplied with THO as drinking water, the largest contribution of OBT to the total accumulated dose was found in the brain. The percent contribution of OBT to the total dose distributed between 17 and 42% among various soft tissues. The OBT localization to cell nuclei increases the microscopic dose to cell nuclei by a factor of 3 – 6 in the case of DNA-bound tritium in comparison with the dose estimated from the tissue-averaged tritium concentration. The tritium localization is of less importance in the case of protein-bound tritium. The blood level tritium was found to be useful and convenient for OBT dosimetry in a practical case of radiation protection of humans after acute and chronic intake of tritium. A new technique was developed to isolate mouse red bone marrow from tibia. A model experiment using mice has shown that the dose to red bone marrow in the case of oral THO intake was lower than the dose estimated for the blood pool.